IMVT vs RSG · $2.90B cap vs P/E 36, rev $9.78B
Immunovant Inc (IMVT) versus Republic Services Inc (RSG) — a side-by-side from cached financials, not a winner call.
Immunovant Inc (IMVT) is a biotechnology company listed on US.
Republic Services Inc (RSG) is a waste management company listed on US.
IMVT does not have a complete income-statement cache yet.
Latest reported RSG revenue for 2026-06-30 was $9.78B. Net income was $1.09B. RSG currently screens at market cap $75.36B and trailing P/E 36.4.
IMVT currently screens at market cap $2.90B. RSG currently screens at market cap $75.36B and trailing P/E 36.4.
Not investment advice. Open the IMVT and RSG stock pages for the full models.
Not investment advice.